{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:58:53Z","timestamp":1771376333217,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T00:00:00Z","timestamp":1523577600000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1038\/s12276-018-0041-1","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T00:54:01Z","timestamp":1523580841000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Interleukin-1 receptor antagonist-mediated neuroprotection by umbilical cord-derived mesenchymal stromal cells following transplantation into a rodent stroke model"],"prefix":"10.1038","volume":"50","author":[{"given":"Seung-Hun","family":"Oh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunggab","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Eun","family":"Noh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Woo","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iksoo","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Min","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Hye","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Sook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ok-Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihwan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,13]]},"reference":[{"key":"41_CR1","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/ana.20501","volume":"57","author":"OY Bang","year":"2005","unstructured":"Bang, O. Y., Lee, J. S., Lee, P. H. & Lee, G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. 57, 874\u2013882 (2005).","journal-title":"Ann. Neurol."},{"key":"41_CR2","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/stem.430","volume":"28","author":"JS Lee","year":"2010","unstructured":"Lee, J. S. et al. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 28, 1099\u20131106 (2010).","journal-title":"Stem Cells"},{"key":"41_CR3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.stem.2012.02.005","volume":"10","author":"SH Ranganath","year":"2012","unstructured":"Ranganath, S. H., Levy, O., Inamdar, M. S. & Karp, J. M. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 10, 244\u2013258 (2012).","journal-title":"Cell Stem Cell"},{"key":"41_CR4","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1634\/stemcells.2007-1028","volume":"26","author":"ML Weiss","year":"2008","unstructured":"Weiss, M. L. et al. Immune properties of human umbilical cord Wharton\u2019s jelly-derived cells. Stem Cells 26, 2865\u20132874 (2008).","journal-title":"Stem Cells"},{"key":"41_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.brainres.2008.06.087","volume":"1229","author":"SH Koh","year":"2008","unstructured":"Koh, S. H. et al. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Brain Res. 1229, 233\u2013248 (2008).","journal-title":"Brain Res."},{"key":"41_CR6","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1161\/STROKEAHA.110.593129","volume":"42","author":"L Zhang","year":"2011","unstructured":"Zhang, L. et al. Delayed administration of human umbilical tissue-derived cells improved neurological functional recovery in a rodent model of focal ischemia. Stroke 42, 1437\u20131444 (2011).","journal-title":"Stroke"},{"key":"41_CR7","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1089\/scd.2013.0067","volume":"22","author":"SM Kim","year":"2013","unstructured":"Kim, S. M. et al. Alternative xeno-free biomaterials derived from human umbilical cord for the self-renewal ex-vivo expansion of mesenchymal stem cells. Stem Cells Dev. 22, 3025\u20133038 (2013).","journal-title":"Stem Cells Dev."},{"key":"41_CR8","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nn.3109","volume":"15","author":"L Bai","year":"2012","unstructured":"Bai, L. et al. Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat. Neurosci. 15, 862\u2013870 (2012).","journal-title":"Nat. Neurosci."},{"key":"41_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","volume":"20","author":"EZ Longa","year":"1989","unstructured":"Longa, E. Z., Weinstein, P. R., Carlson, S. & Cummins, R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20, 84\u201391 (1989).","journal-title":"Stroke"},{"key":"41_CR10","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.3727\/096368912X657314","volume":"22","author":"DJ Chang","year":"2013","unstructured":"Chang, D. J. et al. Therapeutic potential of human induced pluripotent stem cells in experimental stroke. Cell Transplant. 22, 1427\u20131440 (2013).","journal-title":"Cell Transplant."},{"key":"41_CR11","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jcyt.2015.04.007","volume":"17","author":"SH Oh","year":"2015","unstructured":"Oh, S. H. et al. Early neuroprotective effect with lack of long-term cell replacement effect on experimental stroke after intra-arterial transplantation of adipose-derived mesenchymal stromal cells. Cytotherapy 17, 1090\u20131103 (2015).","journal-title":"Cytotherapy"},{"key":"41_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.14348\/molcells.2016.2317","volume":"39","author":"C Choi","year":"2016","unstructured":"Choi, C. et al. Attenuation of post-ischemic genomic alteration by mesenchymal stem cells: a microarray study. Mol. Cells 39, 337\u2013344 (2016).","journal-title":"Mol. Cells"},{"key":"41_CR13","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/nm.2399","volume":"17","author":"C Iadecola","year":"2011","unstructured":"Iadecola, C. & Anrather, J. The immunology of stroke: from mechanisms to translation. Nat. Med. 17, 796\u2013808 (2011).","journal-title":"Nat. Med."},{"key":"41_CR14","doi-asserted-by":"publisher","first-page":"5528","DOI":"10.1523\/JNEUROSCI.21-15-05528.2001","volume":"21","author":"H Boutin","year":"2001","unstructured":"Boutin, H. et al. Role of IL-1alpha and IL-1beta in ischemic brain damage. J. Neurosci. 21, 5528\u20135534 (2001).","journal-title":"J. Neurosci."},{"key":"41_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1161\/01.STR.28.1.155","volume":"28","author":"X Wang","year":"1997","unstructured":"Wang, X., Barone, F. C., Aiyar, N. V. & Feuerstein, G. Z. Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats. Stroke 28, 155\u2013161 (1997).","journal-title":"Stroke"},{"key":"41_CR16","doi-asserted-by":"publisher","first-page":"11002","DOI":"10.1073\/pnas.0704421104","volume":"104","author":"LA Ortiz","year":"2007","unstructured":"Ortiz, L. A. et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc. Natl Acad. Sci. USA 104, 11002\u201311007 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"41_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nm.1905","volume":"15","author":"K Nemeth","year":"2009","unstructured":"Nemeth, K. et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 15, 42\u201349 (2009).","journal-title":"Nat. Med."},{"key":"41_CR18","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1172\/JCI119488","volume":"99","author":"C Gabay","year":"1997","unstructured":"Gabay, C., Smith, M. F., Eidlen, D. & Arend, W. P. Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. J. Clin. Invest. 99, 2930\u20132940 (1997).","journal-title":"J. Clin. Invest."},{"key":"41_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.brainres.2007.09.005","volume":"1183","author":"JM Kim","year":"2007","unstructured":"Kim, J. M. et al. Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model. Brain Res. 1183, 43\u201350 (2007).","journal-title":"Brain Res."},{"key":"41_CR20","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3109\/14653249.2010.549122","volume":"13","author":"Y Ikegame","year":"2011","unstructured":"Ikegame, Y. et al. Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy 13, 675\u2013685 (2011).","journal-title":"Cytotherapy"},{"key":"41_CR21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1179\/174313209X414434","volume":"32","author":"YB Deng","year":"2010","unstructured":"Deng, Y. B. et al. Intravenously administered BMSCs reduce neuronal apoptosis and promote neuronal proliferation through the release of VEGF after stroke in rats. Neurol. Res. 32, 148\u2013156 (2010).","journal-title":"Neurol. Res."},{"key":"41_CR22","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1093\/brain\/awr063","volume":"134","author":"O Honmou","year":"2011","unstructured":"Honmou, O. et al. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 134, 1790\u20131807 (2011).","journal-title":"Brain"},{"key":"41_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.pneurobio.2013.11.007","volume":"115","author":"X Liu","year":"2014","unstructured":"Liu, X. et al. Cell based therapies for ischemic stroke: from basic science to bedside. Prog. Neurobiol. 115, 92\u2013115 (2014).","journal-title":"Prog. Neurobiol."},{"key":"41_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.nbd.2009.10.003","volume":"37","author":"TM Bliss","year":"2010","unstructured":"Bliss, T. M., Andres, R. H. & Steinberg, G. K. Optimizing the success of cell transplantation therapy for stroke. Neurobiol. Dis. 37, 275\u2013283 (2010).","journal-title":"Neurobiol. Dis."},{"key":"41_CR25","doi-asserted-by":"publisher","first-page":"E15","DOI":"10.3171\/FOC\/2008\/24\/3-4\/E14","volume":"24","author":"R Guzman","year":"2008","unstructured":"Guzman, R. et al. Intravascular cell replacement therapy for stroke. Neurosurg. Focus 24, E15 (2008).","journal-title":"Neurosurg. Focus"},{"key":"41_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2003.09.084","volume":"1007","author":"S Iihoshi","year":"2004","unstructured":"Iihoshi, S., Honmou, O., Houkin, K., Hashi, K. & Kocsis, J. D. A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res. 1007, 1\u20139 (2004).","journal-title":"Brain Res."},{"key":"41_CR27","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/jnr.22614","volume":"89","author":"B Yang","year":"2011","unstructured":"Yang, B. et al. Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke. J. Neurosci. Res. 89, 833\u2013839 (2011).","journal-title":"J. Neurosci. Res."},{"key":"41_CR28","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1097\/HJH.0b013e3283396e4e","volume":"28","author":"T Glatz","year":"2010","unstructured":"Glatz, T. et al. Peroxisome-proliferator-activated receptors gamma and peroxisome-proliferator-activated receptors beta\/delta and the regulation of interleukin 1 receptor antagonist expression by pioglitazone in ischaemic brain. J. Hypertens. 28, 1488\u20131497 (2010).","journal-title":"J. Hypertens."},{"key":"41_CR29","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/glia.20308","volume":"53","author":"E Pinteaux","year":"2006","unstructured":"Pinteaux, E., Rothwell, N. J. & Boutin, H. Neuroprotective actions of endogenous interleukin-1 receptor antagonist (IL-1ra) are mediated by glia. Glia 53, 551\u2013556 (2006).","journal-title":"Glia"},{"key":"41_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fncel.2014.00193","volume":"8","author":"M Rosito","year":"2014","unstructured":"Rosito, M. et al. Trasmembrane chemokines CX3CL1 and CXCL16 drive interplay between neurons, microglia and astrocytes to counteract pMCAO and excitotoxic neuronal death. Front. Cell Neurosci. 8, 193 (2014).","journal-title":"Front. Cell Neurosci."},{"key":"41_CR31","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00401-016-1541-5","volume":"131","author":"BH Clausen","year":"2016","unstructured":"Clausen, B. H. et al. Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke. Acta Neuropathol. 131, 775\u2013791 (2016).","journal-title":"Acta Neuropathol."},{"key":"41_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.bbi.2016.11.013","volume":"61","author":"JM Pradillo","year":"2017","unstructured":"Pradillo, J. M. et al. Reparative effects of interleukin-1 receptor antagonist in young and aged\/co-morbid rodents after cerebral ischemia. Brain Behav. Immun. 61, 117\u2013126 (2017).","journal-title":"Brain Behav. Immun."},{"key":"41_CR33","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1136\/jnnp.2004.054882","volume":"76","author":"HC Emsley","year":"2005","unstructured":"Emsley, H. C. et al. A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J. Neurol. Neurosurg. Psychiatry 76, 1366\u20131372 (2005).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"41_CR34","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1189\/jlb.1109766","volume":"87","author":"R Jin","year":"2010","unstructured":"Jin, R., Yang, G. & Li, G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J. Leukoc. Biol. 87, 779\u2013789 (2010).","journal-title":"J. Leukoc. Biol."},{"key":"41_CR35","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1161\/STROKEAHA.112.659656","volume":"43","author":"X Hu","year":"2012","unstructured":"Hu, X. et al. Microglia\/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 43, 3063\u20133070 (2012).","journal-title":"Stroke"},{"key":"41_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pneurobio.2015.05.003","volume":"131","author":"R Franco","year":"2015","unstructured":"Franco, R. & Fernandez-Suarez, D. Alternatively activated microglia and macrophages in the central nervous system. Prog. Neurobiol. 131, 65\u201386 (2015).","journal-title":"Prog. Neurobiol."},{"key":"41_CR37","doi-asserted-by":"publisher","first-page":"17475","DOI":"10.1073\/pnas.0908641106","volume":"106","author":"D Ruffell","year":"2009","unstructured":"Ruffell, D. et al. A CREB-C\/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proc. Natl Acad. Sci. USA 106, 17475\u201317480 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"41_CR38","doi-asserted-by":"crossref","unstructured":"Corbett, G. T., Roy, A. & Pahan, K. Gemfibrozil, a lipid-lowering drug, upregulates IL-1 receptor antagonist in mouse cortical neurons: implications for neuronal self-defense. J. Immunol. 189, 1002\u20131013 (2012).","DOI":"10.4049\/jimmunol.1102624"},{"key":"41_CR39","doi-asserted-by":"publisher","first-page":"e59438","DOI":"10.1371\/journal.pone.0059438","volume":"8","author":"W Im","year":"2013","unstructured":"Im, W. et al. Extracts of adipose derived stem cells slows progression in the R6\/2 model of Huntington\u2019s disease. PLoS ONE 8, e59438 (2013).","journal-title":"PLoS ONE"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-018-0041-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-018-0041-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-018-0041-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T23:29:59Z","timestamp":1630625399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-018-0041-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["41"],"URL":"https:\/\/doi.org\/10.1038\/s12276-018-0041-1","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"5 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}